Clinical Trial Update: Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia [Phase 4]

View source ↗

Summary

Pilot Phase 4 study assessing cefditoren pivoxil in adults with mild to moderate COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• cefditoren pivoxil (cefditoren pivoxil)

Snippet

Sponsor: Meiji Pharma Spain S.A. | Conditions: COVID-19 Pneumonia | Phase 4 | Status: COMPLETED